Clinical Trials Logo

Filter by:
NCT ID: NCT05409027 Completed - Obesity Clinical Trials

A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62

Start date: July 23, 2021
Phase: Phase 1
Study type: Interventional

This will be an exploratory, open-label study of 11β-hydroxysteroid dehydrogenase type 1 (HSD-1) inhibition by SPI-62 in obese subjects with type 2 diabetes mellitus (T2DM)

NCT ID: NCT05409001 Completed - Clinical trials for Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis

Falls From Sitting to Standing

Start date: October 6, 2020
Phase:
Study type: Observational

Background: When evaluating trauma patients, many centers perform computed tomography of the head, cervical spine, chest, abdomen, and pelvis, the so-called "pan-scan." Here, we evaluate the utility of pan-scan in geriatric patients who sustained ground-level falls. Study Design: We performed a retrospective review of consecutive patients from the trauma registry of a large, urban Level 1 trauma center. Inclusion criteria were registration during the 2019 calendar year, age ≥ 65, mechanism of fall from either sitting or standing, and performance of "pan-scan" at time of assessment. Patient demographics, physical exam findings, CT results, injuries, and patient disposition were recorded. The sensitivity, specificity, positive and negative predictive values of the physical exam for significant injuries were calculated.

NCT ID: NCT05408858 Completed - Depression Clinical Trials

LGBTQ-affirmative CBT for Youth

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

This study will adapt LGBTQ-affirmative cognitive behavior therapy (CBT) - previously only used with adults - for youth aged 12-17 years. This intervention addresses the pathways through which minority stress compromises lesbian, gay, bisexual, transgender, and queer (LGBTQ) young peoples' mental health. The purpose of this study is to determine if the intervention is acceptable and feasible for LGBTQ youth.

NCT ID: NCT05408832 Completed - Stress Clinical Trials

Personalized Trials for Stress Management Against Standard of Care

Start date: June 23, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if an N-of-1 study design, or within-subject trials that the investigators are calling "Personalized Trials" can improve health outcomes over standard practice for common stress management techniques. This study uses three different stress management interventions to improve individual self-report of perceived stress: guided mindfulness meditation, guided yoga, and guided brisk walking. Arm 1 (n=53) and Arm 2 (n=53) of the trial will deliver the interventions using a Personalized Trial (within-subject, single N, cross-over trial) format. Participants in Arm 3 of the trial (N=106) will be offered the same number of interventions but will not be required to follow the established N-of-1 Personalized Trials framework. At the end of their Personalized Trial, participants in Arms 1 and 2 will receive a summarized report with personalized feedback. Participants in Arm 3 will also receive a report, but with summarized data . Both arms will receive 2 additional weeks of the stress management intervention of their choosing, while continuing to answer daily assessments and wear a Fitbit device. At the end of the study, a final survey will be sent assessing satisfaction with the study.

NCT ID: NCT05408780 Completed - Alzheimer Disease Clinical Trials

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Start date: July 14, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the PK, safety, and tolerability of a new liquid formulation of tricaprilin.

NCT ID: NCT05408741 Completed - Pain Clinical Trials

A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome

Start date: June 6, 2022
Phase: N/A
Study type: Interventional

To learn if using guided imagery and deep breathing techniques can help with pain management in patients who have post-mastectomy pain syndrome.

NCT ID: NCT05408663 Completed - Safety Issues Clinical Trials

A Phase 1 Study of EXT608 in Healthy Adults

Start date: July 21, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose safety and tolerability study of EXT608 in healthy subjects. There will be up to 6 sequential dose escalation cohorts of 4 participants. In each cohort 3 participants will receive EXT608 and 1 participant will receive placebo.

NCT ID: NCT05408637 Completed - Bipolar Disorder Clinical Trials

Transcranial Photobiomodulation for Executive Function in Bipolar Disorder

TPEB
Start date: August 9, 2022
Phase: Phase 2
Study type: Interventional

Transcranial light therapy, or transcranial photobiomodulation (tPBM), is a treatment that stimulates the brain by applying near-infrared light to the forehead. Transcranial light therapy has been found to promote brain metabolism, which may help improve executive function in people with bipolar disorder. The research team proposes a novel approach to treating bipolar disorder by using transcranial light therapy.

NCT ID: NCT05408468 Completed - Emotion Regulation Clinical Trials

Pilot Evaluation of FAMCOPE-ICU (Family Coping and Emotion Regulation Tool in the ICU)

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

Having a family member or loved one in the ICU can be a very stressful experience. The investigators have created a tablet-based tool (FAMCOPE-ICU) that is designed to help people in this position cope with this experience.

NCT ID: NCT05408390 Completed - Eating Behavior Clinical Trials

Effects of Energy and Physical Density Manipulation on Appetite

Start date: July 5, 2022
Phase: N/A
Study type: Interventional

As individuals tend to eat a constant weight or volume of food, manipulating physical and energy densities generally results in changes in energy intake without affecting subjective appetite sensations. However, relatively few studies have directly studied the interaction between physical and energy density manipulation. This study will determine the effects of foods that systematically vary in physical and energy density on ad libitum energy intake and subjective appetite ratings. Secondary outcomes will include gastrointestinal discomfort, fatigue and acceptability.